Patent details

EP3102212 Title: CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES

Basic Information

Publication number:
EP3102212
PCT Application Number:
NL2014050068
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147052252
PCT Publication Number:
WO2015119495
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
French Title of Invention:
INHIBITEUR DE LA PROTÉINE DE TRANSFERT D'ESTER DE CHOLESTÉRYLE (CETP) ET COMPOSITIONS PHARMACEUTIQUES COMPRENANT LEDIT INHIBITEUR POUR LEUR UTILISATION DANS LE TRAITEMENT OU LA PRÉVENTION DE MALADIES CARDIOVASCULAIRES
German Title of Invention:
CHOLESTERYLESTERTRANSFERPROTEIN (CETP)-INHIBITOR UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT DIESEN INHIBITOR ZUR BEHANDLUNG ODER PRÄVENTION VON KARDIOVASKULÄREN ERKRANKUNGEN
SPC Number:

Dates

Filing date:
05/02/2014
Grant date:
07/11/2018
EP Publication Date:
14/12/2016
PCT Publication Date:
13/08/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/11/2018
EP B1 Publication Date:
07/11/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/02/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/02/2022
 
 

Name:
NewAmsterdam Pharma B.V.
Address:
Gooimeer 2-35, 1411 DC, Naarden, Netherlands (NL)

History of Owners

From:
31/10/2018
To:
23/02/2022

Name:
Dezima Pharma B.V.
Address:
Minervum 7061, 4817 ZK Breda, Netherlands (NL)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
30/01/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
TOMIYASU, Koichi
Address:
Japan (JP)

2

Name:
FORD, John
Address:
United Kingdom (GB)

3

Name:
KAWAGUCHI, Atsuhiro
Address:
Japan (JP)

4

Name:
OKA, Kozo
Address:
Japan (JP)

5

Name:
ROUND, Patrick
Address:
United Kingdom (GB)

6

Name:
KASTELEIN, John
Address:
Netherlands (NL)

Classification

IPC classification:
A61K 31/506; A61P 3/06; A61P 9/00;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2022/04
Publication date:
04/03/2022
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
201845
Publication date:
07/11/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20220000058A
Date Registered:
23/02/2022
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Change of owners name and address
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
NewAmsterdam Pharma B.V.
Address:
Gooimeer 2-35, 1411 DC, Naarden, Netherlands (NL)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
25/03/2025
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
IPAN GMBH
Filing date Document type Number of pages
30/01/2019 Power Of Attorney 1
23/02/2022 Request For Change 1
23/02/2022 Outgoing Correspondence 1
12/02/2019 Outgoing Correspondence 1